Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-24T22:32:56.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-10T15:37:23.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    2%
    Check dated 2025-03-03T13:58:22.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-02-17T12:33:41.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    3%
    Check dated 2025-02-10T08:54:13.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.6%
    Check dated 2025-02-03T04:43:21.000Z thumbnail image

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.